|
gptkbp:instanceOf
|
Controlled substance schedule
|
|
gptkbp:abusePotential
|
High
|
|
gptkbp:contrastsWith
|
Schedule I (USA)
Schedule III (USA)
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:dependenceRisk
|
Severe
|
|
gptkbp:enforcedBy
|
gptkb:Drug_Enforcement_Administration_(DEA)
|
|
gptkbp:establishedBy
|
gptkb:Controlled_Substances_Act_of_1970
|
|
gptkbp:example
|
gptkb:Cocaine
gptkb:Adderall
gptkb:Amphetamine
gptkb:Hydromorphone
gptkb:Methylphenidate
gptkb:Morphine
gptkb:Oxycodone
gptkb:Pentobarbital
gptkb:Secobarbital
gptkb:Methadone
gptkb:Ritalin
Methamphetamine
Fentanyl
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule II (USA)
|
|
gptkbp:legalStatus
|
Prescription only
|
|
gptkbp:medicalUse
|
gptkb:Accepted
|
|
gptkbp:partOf
|
gptkb:Controlled_Substances_Act_(USA)
|
|
gptkbp:prescriptionRequired
|
Written prescription required
No refills allowed
|
|
gptkbp:regulates
|
Drugs with accepted medical use
Drugs with high potential for abuse
Drugs with severe psychological or physical dependence risk
|
|
gptkbp:bfsParent
|
gptkb:BZ_(ICE)
|
|
gptkbp:bfsLayer
|
8
|